Form 4: Frist Sells Select Medical Holdings Shares in Merger

William H. Frist reported a disposition of Select Medical Holdings Corp. common stock following a merger agreement, converting shares into cash consideration.

Summary

• William H. Frist, a Director at Select Medical Holdings Corporation, has reported a transaction involving his beneficial ownership of the company's common stock.
• The transaction occurred on June 30, 2026, and involved the conversion of Frist's shares into cash as part of a merger.
• Each share of common stock was converted into the right to receive $16.50 in cash per share, without interest, as per the Merger Agreement.
• This also includes unvested shares of Company common stock subject to forfeiture conditions, which vested in full prior to the merger and were converted into the Merger Consideration.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports on the completion of a merger and the conversion of shares to cash, which is a factual event rather than an indicator of ongoing operational performance or future growth.

Positives

• The transaction reflects the completion of a merger, indicating a significant corporate event has been finalized.
• Shareholders, including William H. Frist, are receiving cash consideration of $16.50 per share, providing a clear return on their investment.
• All outstanding shares, including restricted stock, were converted, simplifying the ownership structure post-merger.

Negatives

• The disposition of shares by a Director indicates a change in ownership structure and potentially a delisting or significant change in the company's public status.
• The cash-out nature of the transaction means existing shareholders will no longer hold equity in the company.

Risks

• The primary risk is the completion of the merger itself, which has now occurred, converting equity to cash.
• For shareholders who wished to retain equity in Select Medical Holdings, the merger represents a loss of that opportunity.

Future Outlook

The filing indicates the completion of a merger where all outstanding shares were converted into cash. Therefore, there is no forward-looking outlook for Select Medical Holdings as an independent public entity based on this filing.

Management Comments

• The transaction was made pursuant to the Agreement and Plan of Merger.
• Each share of common stock was converted into the right to receive $16.50 per share in cash without interest.
• Unvested restricted shares vested in full as of immediately prior to the effective time of the merger and were converted into the Merger Consideration.

Industry Context

StockSavvy.ai notes that this Form 4 filing signifies the completion of a significant M&A event for Select Medical Holdings Corporation. Such filings are typical in the healthcare services sector during periods of consolidation or strategic repositioning.

Stakeholder Impact

• Shareholders: Will receive $16.50 per share in cash, realizing their investment but losing future equity participation.
• Management: The transaction signifies the culmination of a strategic process, with potential implications for future roles.
• Employees: The impact on employees will depend on the acquiring entity's plans for the business operations and workforce.

Next Steps

• Shareholders will receive the cash consideration for their shares.
• Select Medical Holdings Corporation will likely cease to exist as an independent publicly traded entity following the merger's completion.

Key Dates

Keywords

Form 4, SEC Filing, Select Medical Holdings, William H. Frist, Merger, Stock Disposition, Beneficial Ownership, Common Stock, Cash Consideration